AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene PIGVandZDHHC18.
, go to our main page or see our latest news
Homo sapiens complex locus PIGVandZDHHC18, encoding phosphatidylinositol glycan anchor biosynthesis, class V and zinc finger, DHHC-type containing 18.
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 550 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in lung (seen 48 times), testis (32), brain (19), placenta (17), carcinoid (16), eye (13), prostate (13), kidney (12), uterus (11), whole brain (11), colon (9), pooled human melanocyte, fetal heart, andpregnant uterus (9), stomach (9), amygdala (8), germinal center B cell (8), liver and spleen (8), pancreas (8), hippocampus (7), small intestine (7), breast (6), liver (6), placenta cot 25-normalized (6), b-cell, chronic lymphotic leukemia (5), breast carcinoma (5), ovary (5), adenocarcinoma, cell line (4), ascites (4), breast, tumor tissue (4), chondrosarcoma (4), chondrosarcoma lung metastasis cell lines (4), colon normal (4), epithelioid carcinoma cell line (4), glioblastoma (pooled) (4), heart (4), lymph (4), marrow (4), tongue, tumor tissue (4), adenocarcinoma (3), adenocarcinoma cell line (3), alveolar macrophage (3), cell lines (3), cervix (3), colon, tumor tissue (3), embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells (3), fetal eyes, lens, eye anterior segment,optic nerve, retina, retina foveal and macular, RPE andchoroid (3), human lung epithelial cells (3), hypothalamus (3), large cell carcinoma (3), medulla (3), neuroblastoma cot 10-normalized (3), parathyroid gland (3), poorly differentiated adenocarcinoma withsignet ring cell features (3), skin (3), spleen (3), squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) (3), t-lymphocytes (3), thalamus (3), total brain (3), adipose tissue (2), amnion normal (2), aveolar macrophage (2), bone (2), caudate nucleus (2), corpus callosum (2), duodenal adenocarcinoma, cell line (2), embryonic stem (2), embryonic stem cells, dmso-treated H9 cellline (2), epidermoid carcinoma, cell line (2), fetal eye (2), fibrotheoma (2), head neck (2), hepatoblastoma (2), human placenta (2), hypernephroma, cell line (2), islets of langerhans (2), kidney tumor (2), leiomyosarcoma (2), lung normal (2), lymph node (2), lymphoma, cell line (2), mammary gland (2), melanocyte (2), neuroblastoma cells (2), parathyroid tumor (2), pooled brain, lung, testis (2), pooled germ cell tumors (2), pooled pancreas and spleen (2), retinoblastoma (2), salivary gland (2), serous papillary carcinoma, high grade, 2pooled tumors (2), substantia nigra (2), thyroid (2), thyroid gland (2), trachea (2), uterus tumor (2), adipose (once), adrenal gland (once), alzheimer cortex (once), anaplastic oligodendroglioma (once), anaplastic oligodendroglioma with 1p/19qloss (once), b-cells (once), beard hair (once), brain/cns (once), cerebellum (once), cerebrum (once), cervical carcinoma cell line (once), chondrosarcoma cell line (once), choriocarcinoma (once), colon tumor, RER+ (once), embryonic stem cell, retinoic acid andmitogen-treated hes cell line H7 (once), embryonic stem cells (once), embryonic stem cells, cell lines H1, H7, andh9 (once), epithelioid carcinoma (once), eyeball (once), fetal eyes (once), hela cells cot 25-normalized (once), human brain - frontal cortex (once), human embryonic stem cells (once), human embryonic stem cells differentiated toan early endodermal cell type (once), human retina (once), iris (once), kidney tumor (once), knee (once), large cell carcinoma, undifferentiated (once), left pubic bone (once), lung tumor (once), lung, carcinoma, large cellundifferentiated (once), lymphoma, follicular mixed small and largecell (once), medulloblastoma (once), melanotic melanoma (once), metastatic chondrosarcoma (once), moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors (once), muscle (skeletal) (once), myeloma (once), nervous tumor (once), normal endometrium, mid-secretory phase,cycle day 23 (once), normal nasopharynx (once), osteoarthritic cartilage (once), osteosarcoma, cell line (once), ovary, tumor tissue (once), pineal body (once), pituitary (once), placenta, normal (once), pooled colon, kidney, stomach (once), pooled lung and spleen (once), primary b-cells from tonsils (cell line) (once), primary lung cystic fibrosis epithelialcells (once), primary lung epithelial cells (once), retina (once), small cell carcinoma (once), stomach normal (once), subchondral bone (once), synovial membrane tissue from rheumatioidarthritis (once), T cells (jurkat cell line) (once), T cells (jurkat cell line) cot10-normalized (once), T cells from T cell leukemia (once), teratocarcinoma, cell line (once), thymus (once), thymus, pooled (once), tumor (once).
550 cDNA clones support the 25 variants of gene PIGVandZDHHC18
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
DC357977 | | .a | 1 to 532 | 1 to 533 | | tiling clone, | | 533/533 (100 %) | 1 diff (99.9 %id) |
DA280125 | corpus callosum | .a | 2 to 570 | 2 to 570 | | capped | | 569/569 (100 %) | 1 diff (99.9 %id) |
BI464192 | testis | .a | 9 to 775 | 1 to 768 | | | | 768/768 (100 %) | 12 diff (98.5 %id) |
DA707788 | | .a | 13 to 599 | 2 to 588 | | capped | | 587/587 (100 %) | 0 diff (100 %id) |
DA442963 | tongue, tumor tissue | .a | 15 to 596 | 2 to 583 | | capped | | 582/582 (100 %) | 1 diff (99.9 %id) |
DA527230 | brain | .a | 15 to 593 | 2 to 580 | | capped | | 579/579 (100 %) | 0 diff (100 %id) |
DA749633 | | .a | 15 to 590 | 2 to 577 | | capped | | 576/576 (100 %) | 0 diff (100 %id) |
DB095606 | testis | .a | 15 to 581 | 2 to 569 | | capped | | 568/568 (100 %) | 4 diff (99.3 %id) |
DB055561 | testis | .a | 22 to 604 | 2 to 586 | | capped | | 585/585 (100 %) | 3 diff (99.5 %id) |
DB452190 | testis | .a | 32 to 525 | 1 to 494 | | | | 494/494 (100 %) | 0 diff (100 %id) |
DA345766 | substantia nigra | .a | 34 to 623 | 2 to 591 | | capped | | 590/590 (100 %) | 0 diff (100 %id) |
BI458827 | testis | .a | 34 to 870 | 1 to 839 | | | | 839/842 (99 %) | 35 diff (95.9 %id) |
TI_57172236 | | .a | 47 to 689 | 81 to 723 | | | | 643/726 (88 %) | 8 diff (98.9 %id) |
DB030379 | testis | .a | 47 to 600 | 2 to 556 | | capped | | 555/555 (100 %) | 2 diff (99.7 %id) |
BP299571 | | .a | 54 to 635 | 1 to 582 | | tiling clone, | | 582/582 (100 %) | 0 diff (100 %id) |
DA009486 | adrenal gland | .a | 55 to 618 | 2 to 566 | | capped | | 565/565 (100 %) | 1 diff (99.9 %id) |
DB451648 | testis | .a | 60 to 555 | 1 to 497 | | | | 497/500 (99 %) | 3 diff (99.4 %id) |
BM918442 | pooled pancreas and spleen | .a | 217 to 914 | 1 to 704 | | | | 704/1111 (63 %) | 25 diff (97.8 %id) |
CD628669 | | .a | 225 to 1079 | 1 to 855 | | | | 855/859 (99 %) | 10 diff (98.9 %id) |
CD628671 | | .a | 225 to 1062 | 1 to 834 | | | | 834/837 (99 %) | 13 diff (98.5 %id) |
DA841680 | placenta | .a | 225 to 765 | 2 to 542 | | capped | | 541/541 (100 %) | 3 diff (99.5 %id) |
DA866266 | Prostate | .a | 226 to 784 | 2 to 560 | | capped | | 559/559 (100 %) | 0 diff (100 %id) |
DA276437 | corpus callosum | .a | 227 to 791 | 2 to 566 | | capped | | 565/565 (100 %) | 0 diff (100 %id) |
DA373184 | thalamus | .a | 227 to 847 | 2 to 622 | | capped | | 621/621 (100 %) | 0 diff (100 %id) |
DA463015 | | .a | 227 to 776 | 2 to 551 | | capped | | 550/550 (100 %) | 0 diff (100 %id) |
DA586290 | lung | .a | 227 to 824 | 2 to 599 | | capped | | 598/598 (100 %) | 0 diff (100 %id) |
DA589510 | lung | .a | 227 to 794 | 2 to 569 | | capped | | 568/568 (100 %) | 0 diff (100 %id) |
DA625209 | Kidney | .a | 227 to 772 | 2 to 547 | | capped | | 546/546 (100 %) | 0 diff (100 %id) |
DA633313 | Kidney | .a | 227 to 814 | 2 to 589 | | capped | | 588/588 (100 %) | 0 diff (100 %id) |
DA716979 | | .a | 227 to 782 | 2 to 557 | | capped | | 556/556 (100 %) | 0 diff (100 %id) |
DA831246 | placenta | .a | 227 to 873 | 2 to 652 | | capped | | 651/651 (100 %) | 6 diff (99.1 %id) |
DA873863 | Prostate | .a | 227 to 800 | 2 to 576 | | capped | | 575/575 (100 %) | 1 diff (99.9 %id) |
DB258589 | uterus | .a | 227 to 780 | 2 to 555 | | capped | | 554/554 (100 %) | 1 diff (99.9 %id) |
DA178931 | amygdala | .a | 230 to 798 | 2 to 570 | | capped | | 569/569 (100 %) | 1 diff (99.9 %id) |
DA395285 | thalamus | .a | 230 to 818 | 2 to 590 | | capped | | 589/589 (100 %) | 1 diff (99.9 %id) |
DA464311 | | .a | 230 to 776 | 2 to 548 | | capped | | 547/547 (100 %) | 0 diff (100 %id) |
DB047340 | testis | .a | 230 to 793 | 2 to 565 | | capped | | 564/564 (100 %) | 0 diff (100 %id) |
DA168986 | amygdala | .a | 232 to 791 | 2 to 562 | | capped | | 561/561 (100 %) | 1 diff (99.9 %id) |
DA252624 | caudate nucleus | .a | 233 to 799 | 2 to 569 | | capped | | 568/568 (100 %) | 1 diff (99.9 %id) |
DA534864 | heart | .a | 234 to 804 | 2 to 573 | | capped | | 572/572 (100 %) | 3 diff (99.5 %id) |
DB194066 | ovary, tumor tissue | .a | 234 to 799 | 2 to 567 | | capped | | 566/566 (100 %) | 3 diff (99.5 %id) |
DR003953 | Liver | .a | 239 to 974 | 1 to 736 | | | | 736/736 (100 %) | 5 diff (99.4 %id) |
CR609465 | HeLa cells Cot 25-normalized | .a | 246 to 2247 | 1 to 2002 | exact | tiling clone, | | 2002/2002 (100 %) | 0 diff (100 %id) |
BX401025 | | .a | 1269 to 2247 | 975 to 1 | | | | 975/983 (99 %) | 10 diff (99.0 %id) |
DB376811 | placenta | .a | 1873 to 2264 | 402 to 12 | | | | 391/402 (97 %) | 0 diff (100 %id) |
AI659888 | Prostate | .a | 1902 to 2384 | 484 to 2 | | tiling clone, | | 483/484 (99 %) | 0 diff (100 %id) |
CB216990 | normal endometrium, mid-secretory phase,cycle day 23, uterus | .b | 1 to 716 | 1 to 716 | | tiling clone, | | 716/716 (100 %) | 0 diff (100 %id) |
DA629571 | Kidney | .b | 91 to 665 | 2 to 577 | | capped | | 576/576 (100 %) | 2 diff (99.7 %id) |
DA646300 | mammary gland | .b | 92 to 861 | 2 to 773 | | capped | | 772/781 (98 %) | 6 diff (99.3 %id) |
DA717455 | | .b | 92 to 643 | 2 to 555 | | capped | | 554/554 (100 %) | 3 diff (99.5 %id) |
DB044580 | testis | .b | 99 to 648 | 2 to 551 | | capped | | 550/550 (100 %) | 1 diff (99.9 %id) |
CD251053 | brain, Pituitary | .b | 121 to 968 | 1 to 854 | | tiling clone, | | 854/861 (99 %) | 7 diff (99.2 %id) |
BM560014 | brain, medulla | .b | 131 to 1027 | 1 to 910 | | tiling clone, | | 910/995 (91 %) | 28 diff (97.2 %id) |
DA883042 | | .b | 190 to 745 | 2 to 557 | | capped | | 556/556 (100 %) | 1 diff (99.9 %id) |
DB360960 | mammary gland | .b | 1808 to 2385 | 575 to 1 | | tiling clone, | | 575/576 (99 %) | 8 diff (98.7 %id) |
DB096501 | testis | .c | 1 to 492 | 2 to 493 | | tiling clone, capped | | 492/492 (100 %) | 1 diff (99.8 %id) |
AW665672 | pooled | .c | 270 to 751 | 482 to 1 | | | | 482/482 (100 %) | 5 diff (99.0 %id) |
AI123447 | | .c | 342 to 751 | 410 to 1 | | tiling clone, | | 410/410 (100 %) | 2 diff (99.6 %id) |
BF354845 | head_neck | .c | 417 to 632 | 10 to 227 | | | | 218/227 (96 %) | 12 diff (94.8 %id) |
BU146855 | Spleen | .c | 686 to 1370 | 1 to 695 | | tiling clone, | | 695/996 (69 %) | 14 diff (98.6 %id) |
BP257897 | heart | .c | 1111 to 1690 | 1 to 580 | | | | 580/580 (100 %) | 0 diff (100 %id) |
TI_57172441 | | .c | 1124 to 1817 | 25 to 716 | | | | 692/718 (96 %) | 9 diff (98.8 %id) |
CR625962 | Placenta Cot 25-normalized | .c | 1126 to 2688 | 1 to 1563 | exact | tiling clone, | | 1563/1563 (100 %) | 0 diff (100 %id) |
BX357689 | Placenta Cot 25-normalized | .c | 1126 to 1828 | 1 to 686 | | fully sequenced, | | 686/686 (100 %) | 1 diff (99.9 %id) |
BI828718 | brain, medulla | .c | 1129 to 1817 | 1 to 687 | | | | 687/689 (99 %) | 6 diff (99.2 %id) |
BI769173 | pooled lung and spleen | .c | 1135 to 1909 | 1 to 779 | | | | 779/779 (100 %) | 14 diff (98.3 %id) |
TI_57178527 | | .c | 1136 to 1909 | 30 to 807 | | | | 778/807 (96 %) | 18 diff (97.8 %id) |
TI_57230693 | | .c | 1167 to 1845 | 104 to 793 | | | | 690/825 (83 %) | 26 diff (96.9 %id) |
BI869101 | adenocarcinoma, cell line, Liver | .c | 1168 to 1845 | 1 to 689 | | | | 689/824 (83 %) | 26 diff (96.9 %id) |
CV025424 | mixed | .c | 1189 to 1778 | 1 to 590 | | | | 590/590 (100 %) | 3 diff (99.5 %id) |
TI_1948133457 | | .c | 1189 to 1893 | 128 to 837 | | | | 710/1408 (50 %) | 26 diff (98.2 %id) |
TI_1948133529 | | .c | 1189 to 1980 | 131 to 942 | | | | 812/1372 (59 %) | 42 diff (97.0 %id) |
TI_1948133993 | | .c | 1189 to 1988 | 133 to 937 | | | | 805/1316 (61 %) | 27 diff (98.0 %id) |
TI_1948134538 | | .c | 1189 to 1734 | 129 to 675 | | | | 547/1350 (40 %) | 23 diff (98.3 %id) |
TI_1948134610 | | .c | 1189 to 1948 | 127 to 889 | | | | 763/1291 (59 %) | 38 diff (97.1 %id) |
TI_1948135073 | | .c | 1189 to 2022 | 127 to 971 | | | | 845/1405 (60 %) | 44 diff (96.9 %id) |
CN427396 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .c | 1210 to 1908 | 12 to 710 | | | | 699/710 (98 %) | 6 diff (99.2 %id) |
BX357688 | Placenta Cot 25-normalized | .c | 1798 to 2688 | 880 to 1 | | fully sequenced, | | 880/880 (100 %) | 1 diff (99.9 %id) |
DB341784 | testis | .c | 2838 to 3120 | 289 to 6 | | tiling clone, | | 284/289 (98 %) | 0 diff (100 %id) |
AW968907 | | .d | 1 to 711 | 1 to 710 | | tiling clone, | | 710/711 (99 %) | 13 diff (98.2 %id) |
AA488793 | germinal center B cell | .d | 14 to 298 | 1 to 285 | | | | 285/285 (100 %) | 1 diff (99.7 %id) |
AA489009 | germinal center B cell | .d | 1835 to 2191 | 392 to 36 | | tiling clone, AAA | | 357/357 (100 %) | 0 diff (100 %id) |
DA858628 | placenta | .e | -8 to 591 | 2 to 601 | | tiling clone, capped | | 600/600 (100 %) | 1 diff (99.9 %id) |
DA193540 | amygdala | .e | 30 to 604 | 2 to 576 | | capped | | 575/575 (100 %) | 1 diff (99.9 %id) |
BI463967 | testis | .e | 209 to 1037 | 1 to 828 | | | | 828/828 (100 %) | 15 diff (98.2 %id) |
DA714698 | | .e | 213 to 768 | 2 to 558 | | capped | | 557/557 (100 %) | 2 diff (99.7 %id) |
AK056539 | | .e | 221 to 2933 | 1 to 2713 | A133V | tiling clone, available from FLJ, | | 2713/2713 (100 %) | 3 diff (99.9 %id) |
DA744050 | | .e | 222 to 771 | 2 to 552 | | capped | | 551/551 (100 %) | 2 diff (99.7 %id) |
BG386893 | adenocarcinoma cell line, colon | .e | 235 to 977 | 1 to 742 | | | | 742/873 (84 %) | 12 diff (98.7 %id) |
BG746359 | adenocarcinoma cell line, colon | .e | 235 to 1046 | 1 to 813 | | | | 813/814 (99 %) | 9 diff (98.9 %id) |
DA730728 | | .e | 818 to 1641 | 2 to 820 | | tiling clone, capped | | 819/819 (100 %) | 19 diff (97.7 %id) |
DB362674 | | .e | 2297 to 2841 | 546 to 1 | | tiling clone, | | 546/556 (98 %) | 12 diff (97.9 %id) |
DB324893 | | .e | 2411 to 2933 | 525 to 1 | | | | 525/525 (100 %) | 3 diff (99.5 %id) |
BC013568 | Lung, carcinoma, large cellundifferentiated. | .f | 1 to 2364 | 1 to 2364 | exact | tiling clone, available from MGC, AAA | | 2364/2364 (100 %) | 0 diff (100 %id) |
NM_017837.2 | | .f | 1 to 2364 | 1 to 2364 | exact | RefSeq, AAA | | 2364/2364 (100 %) | 0 diff (100 %id) |
DA752606 | | .f | 14 to 460 | 2 to 448 | | capped | | 447/447 (100 %) | 0 diff (100 %id) |
BE876747 | large cell carcinoma, undifferentiated, lung | .f | 22 to 815 | 1 to 790 | | | | 790/791 (99 %) | 14 diff (98.3 %id) |
BG773240 | testis | .f | 23 to 724 | 1 to 702 | | | | 702/702 (100 %) | 3 diff (99.6 %id) |
DB036074 | testis | .f | 66 to 613 | 2 to 549 | | capped | | 548/548 (100 %) | 1 diff (99.9 %id) |
AA352882 | | .f | 159 to 453 | 1 to 294 | | | | 294/294 (100 %) | 1 diff (99.7 %id) |
DB023601 | testis | .f | 160 to 700 | 2 to 542 | | capped | | 541/541 (100 %) | 0 diff (100 %id) |
DB000408 | breast, tumor tissue | .f | 177 to 715 | 2 to 540 | | capped | | 539/539 (100 %) | 1 diff (99.9 %id) |
DA179147 | amygdala | .f | 178 to 743 | 2 to 567 | | capped | | 566/566 (100 %) | 1 diff (99.9 %id) |
DA578302 | | .f | 178 to 722 | 2 to 546 | | capped | | 545/545 (100 %) | 0 diff (100 %id) |
DA915957 | small intestine | .f | 178 to 700 | 2 to 524 | | capped | | 523/523 (100 %) | 0 diff (100 %id) |
DA965505 | stomach | .f | 178 to 727 | 2 to 551 | | capped | | 550/550 (100 %) | 0 diff (100 %id) |
DB005522 | breast, tumor tissue | .f | 178 to 710 | 2 to 534 | | capped | | 533/533 (100 %) | 0 diff (100 %id) |
DB043237 | testis | .f | 178 to 750 | 2 to 574 | | capped | | 573/573 (100 %) | 0 diff (100 %id) |
DB059617 | testis | .f | 178 to 684 | 2 to 508 | | capped | | 507/507 (100 %) | 0 diff (100 %id) |
DA137182 | alzheimer cortex | .f | 181 to 708 | 2 to 529 | | capped | | 528/528 (100 %) | 0 diff (100 %id) |
DA596692 | | .f | 183 to 665 | 2 to 484 | | capped | | 483/485 (99 %) | 2 diff (99.6 %id) |
DA350201 | substantia nigra | .f | 184 to 706 | 2 to 524 | | capped | | 523/523 (100 %) | 0 diff (100 %id) |
DA848850 | placenta | .f | 184 to 753 | 2 to 571 | | capped | | 570/570 (100 %) | 0 diff (100 %id) |
DB005113 | breast, tumor tissue | .f | 184 to 721 | 2 to 539 | | capped | | 538/538 (100 %) | 0 diff (100 %id) |
DA428710 | colon | .f | 186 to 747 | 2 to 563 | | capped | | 562/562 (100 %) | 0 diff (100 %id) |
AK000484 | | .f | 194 to 2263 | 1 to 2070 | I33T | available from FLJ, AAA | | 2070/2070 (100 %) | 1 diff (100.0 %id) |
AK225521 | | .f | 194 to 2263 | 1 to 2070 | I33T | AAA | | 2070/2070 (100 %) | 1 diff (100.0 %id) |
DB453907 | testis | .f | 197 to 686 | 1 to 490 | | | | 490/490 (100 %) | 0 diff (100 %id) |
DA125839 | cerebellum | .f | 202 to 684 | 2 to 484 | | capped | | 483/483 (100 %) | 0 diff (100 %id) |
DB166167 | thyroid gland | .f | 202 to 906 | 2 to 706 | | capped | | 705/711 (99 %) | 1 diff (99.9 %id) |
BX401026 | | .f | 214 to 1162 | 1 to 936 | | | | 936/969 (96 %) | 16 diff (98.4 %id) |
BI457165 | epithelioid carcinoma cell line, Pancreas | .f | 217 to 1172 | 1 to 942 | | | | 942/947 (99 %) | 36 diff (96.2 %id) |
TI_45133405 | | .f | 218 to 1172 | 59 to 999 | | | | 941/946 (99 %) | 35 diff (96.4 %id) |
R78517 | placenta | .f | 229 to 713 | 1 to 481 | | | Submitted on the opposite strand | 481/481 (100 %) | 13 diff (97.3 %id) |
CX785256 | human embryonic stem cells | .f | 253 to 1079 | 1 to 827 | | | | 827/827 (100 %) | 0 diff (100 %id) |
TI_182940165 | | .f | 267 to 1257 | 1055 to 83 | | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 973/1082 (89 %) | 13 diff (98.8 %id) |
BX462667 | T cells (Jurkat cell line) | .f | 278 to 1419 | 1 to 1128 | | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 1128/1132 (99 %) | 26 diff (97.8 %id) |
TI_1948133455 | | .f | 332 to 1484 | 138 to 1293 | | | | 1156/1334 (86 %) | 70 diff (94.8 %id) |
TI_1948133456 | | .f | 332 to 1244 | 125 to 1042 | | | | 918/1364 (67 %) | 37 diff (97.3 %id) |
TI_1948133527 | | .f | 332 to 1362 | 141 to 1162 | | | | 1022/1284 (79 %) | 25 diff (98.1 %id) |
TI_1948133528 | | .f | 332 to 1408 | 134 to 1184 | | | | 1051/1311 (80 %) | 45 diff (96.6 %id) |
TI_1948133991 | | .f | 332 to 1285 | 137 to 1086 | | | | 950/1358 (69 %) | 41 diff (97.0 %id) |
TI_1948133992 | | .f | 332 to 1484 | 126 to 1266 | | | | 1141/1331 (85 %) | 91 diff (93.2 %id) |
TI_1948134063 | | .f | 332 to 1484 | 133 to 1285 | | | | 1153/1365 (84 %) | 44 diff (96.8 %id) |
TI_1948134064 | | .f | 332 to 1493 | 127 to 1277 | | | | 1151/1343 (85 %) | 64 diff (95.3 %id) |
TI_1948134065 | | .f | 332 to 1247 | 127 to 1049 | | | | 923/1303 (70 %) | 31 diff (97.7 %id) |
TI_1948134536 | | .f | 332 to 1431 | 139 to 1242 | | | | 1104/1420 (77 %) | 55 diff (96.2 %id) |
TI_1948134537 | | .f | 332 to 1233 | 130 to 1030 | | | | 901/1321 (68 %) | 32 diff (97.6 %id) |
TI_1948134608 | | .f | 332 to 1281 | 136 to 1094 | | | | 959/1376 (69 %) | 24 diff (98.3 %id) |
TI_1948134609 | | .f | 332 to 1321 | 135 to 1118 | | | | 984/1367 (71 %) | 45 diff (96.8 %id) |
TI_1948135071 | | .f | 332 to 1115 | 139 to 922 | | | | 784/1416 (55 %) | 11 diff (99.3 %id) |
TI_1948135072 | | .f | 332 to 1315 | 126 to 1107 | | | | 982/1320 (74 %) | 36 diff (97.3 %id) |
AW752014 | colon | .f | 437 to 866 | 430 to 1 | | | | 430/430 (100 %) | 22 diff (94.9 %id) |
BE387610 | melanotic melanoma, skin | .f | 446 to 1029 | 46 to 633 | | | | 588/633 (92 %) | 6 diff (99.1 %id) |
CD628668 | | .f | 471 to 1198 | 744 to 18 | | | | 727/744 (97 %) | 0 diff (100 %id) |
DA151819 | amygdala | .f | 496 to 1054 | 2 to 560 | | capped | | 559/559 (100 %) | 0 diff (100 %id) |
AA309914 | | .f | 583 to 990 | 1 to 409 | | | | 409/409 (100 %) | 1 diff (99.8 %id) |
CN480741 | Aveolar Macrophage, lung | .f | 626 to 1257 | 649 to 18 | | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 632/649 (97 %) | 0 diff (100 %id) |
CD628670 | | .f | 639 to 1198 | 577 to 18 | | | | 560/577 (97 %) | 0 diff (100 %id) |
BP350867 | | .f | 670 to 1255 | 1 to 587 | | | | 587/587 (100 %) | 2 diff (99.7 %id) |
TI_1948134067 | | .f | 679 to 1815 | 1257 to 125 | | | | 1133/1311 (86 %) | 58 diff (95.6 %id) |
TI_1948133531 | | .f | 685 to 1815 | 1235 to 126 | | | | 1110/1262 (87 %) | 43 diff (96.6 %id) |
DB011248 | colon, tumor tissue | .f | 693 to 1210 | 2 to 519 | | capped | | 518/518 (100 %) | 0 diff (100 %id) |
CX867610 | embryonic stem | .f | 726 to 1553 | 1 to 828 | | | | 828/828 (100 %) | 0 diff (100 %id) |
TI_1948134068 | | .f | 792 to 1815 | 1149 to 125 | | | | 1025/1150 (89 %) | 21 diff (98.2 %id) |
TI_1948135148 | | .f | 792 to 1815 | 1144 to 123 | | | | 1022/1148 (89 %) | 40 diff (96.6 %id) |
TI_1948134613 | | .f | 793 to 1815 | 1150 to 123 | | | | 1028/1150 (89 %) | 44 diff (96.2 %id) |
TI_1948135147 | | .f | 797 to 1815 | 1149 to 130 | | | | 1020/1313 (77 %) | 35 diff (97.4 %id) |
TI_1948133996 | | .f | 803 to 1815 | 1141 to 124 | | | | 1018/1150 (88 %) | 33 diff (97.2 %id) |
TI_1948133532 | | .f | 804 to 1815 | 1137 to 124 | | | | 1014/1147 (88 %) | 18 diff (98.5 %id) |
TI_1948134540 | | .f | 805 to 1815 | 1137 to 125 | | | | 1013/1297 (78 %) | 32 diff (97.6 %id) |
BG741615 | skin | .f | 815 to 1566 | 1 to 750 | | | | 750/752 (99 %) | 8 diff (99.0 %id) |
TI_1948133459 | | .f | 818 to 1815 | 1113 to 125 | | | | 989/1270 (77 %) | 25 diff (98.1 %id) |
TI_1948134541 | | .f | 830 to 1815 | 1116 to 123 | | | | 994/1156 (85 %) | 31 diff (97.4 %id) |
TI_1948134612 | | .f | 844 to 1815 | 1100 to 127 | | | | 974/1288 (75 %) | 21 diff (98.4 %id) |
TI_1948135076 | | .f | 844 to 1812 | 1095 to 124 | | | | 972/1147 (84 %) | 30 diff (97.4 %id) |
TI_1948135075 | | .f | 862 to 1812 | 1084 to 125 | | | | 960/1373 (69 %) | 52 diff (96.3 %id) |
BX390699 | | .f | 882 to 1497 | 1 to 613 | | | | 613/622 (98 %) | 18 diff (97.2 %id) |
TI_1948134066 | | .f | 898 to 1815 | 1047 to 124 | | | | 924/1280 (72 %) | 21 diff (98.4 %id) |
TI_1948133460 | | .f | 899 to 1815 | 1048 to 123 | | | | 926/1163 (79 %) | 19 diff (98.4 %id) |
BG982504 | colon_normal | .f | 903 to 1364 | 1 to 461 | | | | 461/462 (99 %) | 4 diff (99.2 %id) |
TI_1948135146 | | .f | 905 to 1815 | 1041 to 123 | | | | 919/1279 (71 %) | 30 diff (97.7 %id) |
TI_1948134611 | | .f | 913 to 1815 | 1031 to 120 | | | | 912/1305 (69 %) | 40 diff (97.0 %id) |
TI_1948133995 | | .f | 915 to 1815 | 1028 to 122 | | | | 907/1388 (65 %) | 16 diff (98.9 %id) |
FN131343 | breast carcinoma | .f | 940 to 1032 | 93 to 1 | | | Submitted on the opposite strand | 93/93 (100 %) | 0 diff (100 %id) |
TI_1948133458 | | .f | 947 to 1815 | 994 to 123 | | | | 872/1295 (67 %) | 26 diff (98.0 %id) |
TI_1948133530 | | .f | 976 to 1815 | 968 to 126 | | | | 843/1312 (64 %) | 15 diff (98.9 %id) |
TI_1948135074 | | .f | 1016 to 1812 | 949 to 137 | | | | 813/1307 (62 %) | 85 diff (93.5 %id) |
BG435977 | placenta | .f | 1060 to 1703 | 1 to 648 | | | | 648/667 (97 %) | 14 diff (98.0 %id) |
TI_1948133994 | | .f | 1094 to 1815 | 855 to 118 | | | | 738/1347 (54 %) | 31 diff (97.7 %id) |
CA306927 | Alveolar Macrophage, lung | .f | 1160 to 1885 | 738 to 16 | | AAA | | 723/723 (100 %) | 3 diff (99.6 %id) |
N98886 | lung | .f | 1205 to 1489 | 1 to 284 | | | | 284/284 (100 %) | 5 diff (98.3 %id) |
BG985124 | colon_normal | .f | 1257 to 1654 | 407 to 9 | | | | 399/407 (98 %) | 4 diff (99.1 %id) |
BG983188 | colon_normal | .f | 1265 to 1606 | 341 to 1 | | | | 341/341 (100 %) | 4 diff (98.9 %id) |
N46021 | melanocyte | .f | 1265 to 1704 | 1 to 441 | | | | 441/441 (100 %) | 5 diff (98.9 %id) |
AI813708 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .f | 1271 to 1889 | 621 to 2 | | | | 620/621 (99 %) | 7 diff (98.9 %id) |
AW962262 | | .f | 1314 to 1887 | 575 to 1 | | | Submitted on the opposite strand | 575/575 (100 %) | 22 diff (96.2 %id) |
BX282734 | leiomyosarcoma, uterus | .f | 1314 to 1789 | 1 to 476 | | | | 476/476 (100 %) | 1 diff (99.8 %id) |
BM459640 | leiomyosarcoma, uterus | .f | 1314 to 2118 | 28 to 838 | | | | 811/972 (83 %) | 19 diff (98.1 %id) |
FN049960 | breast carcinoma | .f | 1321 to 1419 | 98 to 1 | | | Submitted on the opposite strand | 98/98 (100 %) | 1 diff (99.0 %id) |
TI_149313603 | | .f | 1345 to 2268 | 1003 to 88 | | AAA | | 916/986 (92 %) | 20 diff (98.0 %id) |
AI654923 | pooled germ cell tumors | .f | 1424 to 1888 | 465 to 1 | | | | 465/465 (100 %) | 0 diff (100 %id) |
CB049838 | Prostate | .f | 1507 to 2030 | 14 to 537 | | | | 524/537 (97 %) | 7 diff (98.7 %id) |
CB305477 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .f | 1515 to 2268 | 773 to 19 | | AAA | | 755/755 (100 %) | 3 diff (99.7 %id) |
TI_154052477 | | .f | 1534 to 2263 | 856 to 134 | | AAA | | 723/902 (80 %) | 27 diff (97.1 %id) |
AI024609 | | .f | 1541 to 1889 | 361 to 13 | | AAA | | 349/349 (100 %) | 9 diff (97.5 %id) |
CD370164 | Alveolar Macrophage, lung | .f | 1558 to 2263 | 724 to 19 | | AAA | | 706/706 (100 %) | 0 diff (100 %id) |
BU631917 | cell lines, Chondrosarcoma | .f | 1576 to 2270 | 714 to 19 | | AAA | | 696/697 (99 %) | 3 diff (99.6 %id) |
BQ188569 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .f | 1607 to 2311 | 1 to 705 | | | | 705/705 (100 %) | 2 diff (99.8 %id) |
AA203365 | liver and spleen | .f | 1621 to 2224 | 1 to 597 | | | | 597/847 (70 %) | 16 diff (98.2 %id) |
BG983187 | colon_normal | .f | 1622 to 1725 | 104 to 1 | | | | 104/104 (100 %) | 1 diff (99.1 %id) |
EC527017 | Prostate | .f | 1642 to 1749 | 108 to 1 | | | | 108/108 (100 %) | 0 diff (100 %id) |
BQ773550 | Chondrosarcoma Cell line | .f | 1648 to 2364 | 731 to 17 | | AAA | | 715/715 (100 %) | 2 diff (99.8 %id) |
R77192 | placenta | .f | 1667 to 2209 | 4 to 556 | | | | 553/565 (97 %) | 22 diff (96.2 %id) |
CA425851 | cell lines, Chondrosarcoma | .f | 1689 to 2362 | 692 to 19 | | AAA | | 674/674 (100 %) | 0 diff (100 %id) |
AW300554 | Kidney | .f | 1760 to 2266 | 508 to 2 | | | | 507/508 (99 %) | 0 diff (100 %id) |
BE857681 | Prostate | .f | 1763 to 2266 | 505 to 2 | | | | 504/505 (99 %) | 0 diff (100 %id) |
AA252931 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .f | 1776 to 2073 | 1 to 298 | | fully sequenced, | | 298/298 (100 %) | 0 diff (100 %id) |
CX867528 | embryonic stem | .f | 1785 to 2370 | 613 to 28 | | AAA | | 586/586 (100 %) | 1 diff (99.9 %id) |
AW026370 | brain, glioblastoma (pooled) | .f | 1786 to 2265 | 480 to 1 | | | | 480/480 (100 %) | 0 diff (100 %id) |
DB518676 | testis | .f | 1797 to 2263 | 1 to 466 | | | Submitted on the opposite strand | 466/467 (99 %) | 2 diff (99.6 %id) |
DB382122 | thyroid gland | .f | 1802 to 2370 | 576 to 1 | | | | 576/576 (100 %) | 12 diff (98.0 %id) |
DB540873 | hippocampus | .f | 1803 to 2268 | 1 to 466 | | | Submitted on the opposite strand | 466/466 (100 %) | 0 diff (100 %id) |
AW612414 | Kidney | .f | 1810 to 2247 | 438 to 1 | | | | 438/438 (100 %) | 0 diff (100 %id) |
DB523770 | testis | .f | 1817 to 2269 | 1 to 453 | | | Submitted on the opposite strand | 453/453 (100 %) | 0 diff (100 %id) |
DB567289 | hypothalamus | .f | 1817 to 2263 | 1 to 447 | | | Submitted on the opposite strand | 447/447 (100 %) | 0 diff (100 %id) |
AW299408 | Kidney | .f | 1820 to 2263 | 453 to 9 | | | | 445/453 (98 %) | 0 diff (100 %id) |
DB517739 | testis | .f | 1824 to 2263 | 1 to 440 | | | Submitted on the opposite strand | 440/440 (100 %) | 2 diff (99.6 %id) |
DB517129 | testis | .f | 1827 to 2269 | 1 to 443 | | | Submitted on the opposite strand | 443/443 (100 %) | 0 diff (100 %id) |
AA629258 | | .f | 1829 to 2270 | 456 to 13 | | AAA | | 444/444 (100 %) | 13 diff (97.1 %id) |
DB516221 | testis | .f | 1831 to 2263 | 1 to 433 | | | Submitted on the opposite strand | 433/433 (100 %) | 1 diff (99.8 %id) |
AA149537 | colon, tumor | .f | 1836 to 2362 | 515 to 1 | | | | 515/524 (98 %) | 14 diff (97.4 %id) |
DB532053 | hippocampus | .f | 1837 to 2263 | 1 to 428 | | | Submitted on the opposite strand | 428/428 (100 %) | 1 diff (99.8 %id) |
N70033 | lung | .f | 1837 to 2266 | 432 to 2 | | | | 431/432 (99 %) | 0 diff (100 %id) |
DB519360 | testis | .f | 1838 to 2266 | 1 to 429 | | | Submitted on the opposite strand | 429/431 (99 %) | 2 diff (99.6 %id) |
DB546711 | hippocampus | .f | 1843 to 2268 | 1 to 426 | | | Submitted on the opposite strand | 426/426 (100 %) | 0 diff (100 %id) |
AI859872 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .f | 1854 to 2363 | 511 to 2 | | | | 510/511 (99 %) | 0 diff (100 %id) |
AA977420 | Kidney, kidney tumor | .f | 1861 to 2269 | 410 to 2 | | | | 409/410 (99 %) | 0 diff (100 %id) |
BF941586 | carcinoid, lung | .f | 1940 to 2347 | 1 to 408 | | | Submitted on the opposite strand | 408/408 (100 %) | 1 diff (99.8 %id) |
BF511106 | | .f | 1942 to 2263 | 339 to 18 | | AAA | | 322/332 (96 %) | 0 diff (100 %id) |
AI768599 | Kidney | .f | 1943 to 2263 | 340 to 19 | | AAA | | 322/322 (100 %) | 2 diff (99.4 %id) |
N69894 | lung | .f | 1948 to 2271 | 324 to 1 | | | | 374/394 (94 %) | 10 diff (97.5 %id) |
AI420563 | Prostate | .f | 1975 to 2263 | 289 to 1 | | | | 289/289 (100 %) | 0 diff (100 %id) |
AI810949 | Prostate | .f | 1975 to 2263 | 289 to 1 | | | | 289/289 (100 %) | 3 diff (99.0 %id) |
BF476029 | Prostate | .f | 1975 to 2263 | 289 to 1 | | | | 289/289 (100 %) | 0 diff (100 %id) |
BF222172 | Prostate | .f | 1975 to 2263 | 289 to 1 | | | | 289/289 (100 %) | 0 diff (100 %id) |
AI472810 | pooled | .f | 1983 to 2263 | 301 to 21 | | AAA | | 281/281 (100 %) | 0 diff (100 %id) |
AI698854 | colon | .f | 2027 to 2263 | 247 to 11 | | AAA | | 237/237 (100 %) | 2 diff (99.2 %id) |
AA252888 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .f | 2043 to 2264 | 222 to 1 | | fully sequenced, | | 222/222 (100 %) | 0 diff (100 %id) |
Z38327 | brain, total brain | .f | 2053 to 2269 | 217 to 1 | | | | 217/217 (100 %) | 0 diff (100 %id) |
FN063955 | breast carcinoma | .f | 2056 to 2143 | 1 to 88 | | | | 88/89 (98 %) | 1 diff (98.9 %id) |
CK903375 | Islets of Langerhans, Pancreas | .f | 2063 to 2270 | 11 to 218 | | AAA | | 208/218 (95 %) | 8 diff (96.4 %id) |
FN075810 | breast carcinoma | .f | 2068 to 2131 | 63 to 1 | | | Submitted on the opposite strand | 63/64 (98 %) | 2 diff (96.9 %id) |
BI962814 | Islets of Langerhans, Pancreas | .f | 2096 to 2271 | 1 to 176 | | | | 176/189 (93 %) | 1 diff (99.5 %id) |
EC476387 | Prostate | .f | 2102 to 2209 | 1 to 105 | | | | 105/105 (100 %) | 3 diff (97.2 %id) |
AA488535 | | .f | 2108 to 2264 | 1 to 157 | | fully sequenced, | | 157/157 (100 %) | 0 diff (100 %id) |
AI187721 | | .f | 2122 to 2365 | 249 to 6 | | | | 244/249 (97 %) | 0 diff (100 %id) |
AI803900 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .f | 2133 to 2263 | 131 to 1 | | | | 131/131 (100 %) | 1 diff (99.3 %id) |
AA488402 | | .f | 2180 to 2262 | 83 to 1 | | fully sequenced, | | 83/83 (100 %) | 0 diff (100 %id) |
FN050463 | breast carcinoma | .f | 2206 to 2268 | 1 to 64 | | | | 64/73 (87 %) | 2 diff (97.3 %id) |
CF994829 | Human Placenta, placenta | .g | 1 to 527 | 24 to 558 | | tiling clone, | | 535/876 (61 %) | 18 diff (98.0 %id) |
BY798469 | eye | .g | 14 to 361 | 1 to 348 | | | | 348/348 (100 %) | 1 diff (99.8 %id) |
CN417619 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .g | 16 to 162 | 1 to 147 | | | | 147/147 (100 %) | 0 diff (100 %id) |
CB960671 | Human Placenta, placenta | .g | 18 to 616 | 21 to 625 | | | | 605/834 (72 %) | 18 diff (97.9 %id) |
BC066776 | Placenta, normal | .g | 25 to 3159 | 1 to 3135 | exact | tiling clone, available from MGC, AAA | | 3135/3135 (100 %) | 2 diff (100.0 %id) |
NM_032283.2 | | .g | 25 to 3163 | 1 to 3139 | exact | RefSeq, AAA | | 3139/3139 (100 %) | 0 diff (100 %id) |
CN417620 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .g | 56 to 242 | 7 to 193 | | | | 187/193 (96 %) | 0 diff (100 %id) |
BQ064123 | lymph, lymphoma, cell line | .g | 67 to 615 | 1 to 550 | | | | 550/1187 (46 %) | 9 diff (99.3 %id) |
BQ063758 | lymph, lymphoma, cell line | .g | 69 to 812 | 1 to 750 | | | | 750/1117 (67 %) | 14 diff (98.8 %id) |
AK056427 | | .g | 273 to 3159 | 1 to 2887 | | available from FLJ, | | 2887/2887 (100 %) | 1 diff (100.0 %id) |
DA739838 | | .g | 274 to 809 | 2 to 537 | | capped | | 536/536 (100 %) | 0 diff (100 %id) |
DA988602 | synovial membrane tissue from rheumatioidarthritis | .g | 336 to 896 | 2 to 562 | | capped | | 561/561 (100 %) | 0 diff (100 %id) |
BI031815 | marrow | .g | 349 to 636 | 1 to 288 | | | | 288/288 (100 %) | 10 diff (96.6 %id) |
CV337679 | marrow | .g | 349 to 613 | 1 to 265 | | | | 265/267 (99 %) | 20 diff (92.6 %id) |
AI458587 | carcinoid, lung | .g | 364 to 829 | 1 to 466 | | | Submitted on the opposite strand | 466/466 (100 %) | 6 diff (98.8 %id) |
AI702629 | carcinoid, lung | .g | 364 to 731 | 1 to 368 | | | Submitted on the opposite strand | 368/368 (100 %) | 6 diff (98.4 %id) |
BE219592 | carcinoid, lung | .g | 364 to 832 | 1 to 469 | | | Submitted on the opposite strand | 469/469 (100 %) | 2 diff (99.6 %id) |
BE676284 | B-cell, chronic lymphotic leukemia | .g | 364 to 952 | 1 to 589 | | | Submitted on the opposite strand | 589/596 (98 %) | 1 diff (99.9 %id) |
BE676622 | B-cell, chronic lymphotic leukemia | .g | 364 to 1055 | 1 to 692 | | | Submitted on the opposite strand | 692/701 (98 %) | 3 diff (99.6 %id) |
BF512598 | | .g | 365 to 881 | 1 to 517 | | | Submitted on the opposite strand | 517/517 (100 %) | 0 diff (100 %id) |
AA649240 | germinal center B cell | .g | 375 to 852 | 1 to 477 | | | Submitted on the opposite strand | 477/498 (95 %) | 9 diff (98.2 %id) |
AI192787 | lung | .g | 382 to 863 | 1 to 482 | | | Submitted on the opposite strand | 482/482 (100 %) | 0 diff (100 %id) |
BE675384 | B-cell, chronic lymphotic leukemia | .g | 382 to 952 | 1 to 571 | | | Submitted on the opposite strand | 571/578 (98 %) | 6 diff (99.0 %id) |
BE676722 | B-cell, chronic lymphotic leukemia | .g | 382 to 809 | 1 to 428 | | | Submitted on the opposite strand | 428/428 (100 %) | 3 diff (99.3 %id) |
BF732785 | fibrotheoma, ovary | .g | 391 to 1012 | 1 to 622 | | | Submitted on the opposite strand | 622/623 (99 %) | 8 diff (98.8 %id) |
AI306508 | carcinoid, lung | .g | 392 to 838 | 1 to 447 | | | Submitted on the opposite strand | 447/447 (100 %) | 2 diff (99.6 %id) |
AI702490 | Kidney | .g | 393 to 784 | 1 to 393 | | | Submitted on the opposite strand | 393/393 (100 %) | 1 diff (99.8 %id) |
AI692396 | carcinoid, lung | .g | 393 to 832 | 1 to 440 | | | Submitted on the opposite strand | 440/440 (100 %) | 2 diff (99.6 %id) |
AI922342 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .g | 393 to 848 | 1 to 456 | | | Submitted on the opposite strand | 456/456 (100 %) | 0 diff (100 %id) |
AW004949 | colon | .g | 393 to 856 | 1 to 465 | | | Submitted on the opposite strand | 465/465 (100 %) | 1 diff (99.8 %id) |
AW027307 | thymus, pooled | .g | 393 to 952 | 1 to 560 | | | Submitted on the opposite strand | 560/567 (98 %) | 1 diff (99.9 %id) |
AA970466 | pooled | .g | 402 to 822 | 1 to 421 | | | Submitted on the opposite strand | 421/421 (100 %) | 0 diff (100 %id) |
BF433632 | carcinoid, lung | .g | 417 to 831 | 1 to 415 | | | Submitted on the opposite strand | 415/415 (100 %) | 2 diff (99.6 %id) |
AL512765 | lymph node | .g | 420 to 3163 | 1 to 2744 | | tiling clone, available from DKFZ, AAA | | 2744/2744 (100 %) | 0 diff (100 %id) |
AA215473 | germinal center B cell | .g | 446 to 809 | 1 to 375 | | | Submitted on the opposite strand | 375/400 (93 %) | 13 diff (96.8 %id) |
AI221716 | pooled | .g | 446 to 784 | 1 to 339 | | | Submitted on the opposite strand | 339/339 (100 %) | 0 diff (100 %id) |
AI739298 | colon, colon tumor, RER+ | .g | 446 to 863 | 1 to 418 | | | Submitted on the opposite strand | 418/418 (100 %) | 0 diff (100 %id) |
BM932323 | pooled brain, lung, testis | .g | 451 to 1188 | 1 to 742 | | | | 742/1095 (67 %) | 14 diff (98.8 %id) |
BM922087 | pooled brain, lung, testis | .g | 451 to 1130 | 1 to 689 | | | | 687/1003 (68 %) | 14 diff (98.7 %id) |
BE502916 | carcinoid, lung | .g | 455 to 832 | 10 to 387 | | | Submitted on the opposite strand | 378/387 (97 %) | 6 diff (98.5 %id) |
AW176021 | breast | .g | 460 to 964 | 1 to 506 | | | | 506/506 (100 %) | 4 diff (99.3 %id) |
DA733035 | | .g | 483 to 1163 | 2 to 691 | | capped | | 690/690 (100 %) | 16 diff (97.7 %id) |
DA734193 | | .g | 489 to 1034 | 2 to 547 | | capped | | 546/546 (100 %) | 0 diff (100 %id) |
DA024453 | | .g | 498 to 1069 | 2 to 573 | | capped | | 572/572 (100 %) | 1 diff (99.9 %id) |
BF852183 | lung_normal | .g | 523 to 1023 | 498 to 1 | | | Submitted on the opposite strand | 498/499 (99 %) | 6 diff (98.8 %id) |
BQ329361 | lung_normal | .g | 524 to 1023 | 1 to 501 | | | | 501/501 (100 %) | 7 diff (98.7 %id) |
DA735829 | | .g | 531 to 1238 | 2 to 708 | | capped | | 707/707 (100 %) | 2 diff (99.8 %id) |
DA734064 | | .g | 618 to 1055 | 2 to 435 | | capped | | 434/475 (91 %) | 9 diff (98.2 %id) |
DB001499 | breast, tumor tissue | .g | 632 to 1171 | 2 to 541 | | capped | | 540/540 (100 %) | 0 diff (100 %id) |
CN425769 | embryonic stem cells, DMSO-treated H9 cellline | .g | 638 to 1365 | 9 to 738 | | | | 730/738 (98 %) | 9 diff (98.8 %id) |
AI286059 | pooled | .g | 686 to 824 | 1 to 139 | | | Submitted on the opposite strand | 139/139 (100 %) | 5 diff (96.5 %id) |
AI939916 | breast | .g | 687 to 1174 | 514 to 14 | | | | 514/514 (100 %) | 63 diff (87.8 %id) |
CO248663 | Chondrosarcoma Lung Metastasis cell lines, lung | .g | 690 to 1261 | 1 to 568 | | | | 568/750 (75 %) | 27 diff (96.4 %id) |
CO247881 | Chondrosarcoma Lung Metastasis cell lines, lung | .g | 690 to 1287 | 1 to 589 | | | | 589/727 (81 %) | 22 diff (97.0 %id) |
D63224 | | .g | 716 to 1069 | 1 to 354 | | | | 354/354 (100 %) | 11 diff (96.9 %id) |
AW407639 | lymph | .g | 766 to 1165 | 1 to 401 | | | | 401/401 (100 %) | 5 diff (98.8 %id) |
TI_154146174 | | .g | 767 to 1590 | 94 to 911 | | | | 818/915 (89 %) | 89 diff (90.3 %id) |
TI_154147230 | | .g | 772 to 1398 | 81 to 707 | | | | 627/629 (99 %) | 16 diff (97.5 %id) |
AI814810 | adenocarcinoma, Pancreas | .g | 773 to 989 | 1 to 217 | | | Submitted on the opposite strand | 217/220 (98 %) | 14 diff (93.7 %id) |
BQ379770 | uterus_tumor | .g | 779 to 1203 | 15 to 439 | | | | 425/439 (96 %) | 13 diff (97.1 %id) |
BF821345 | kidney_tumor | .g | 804 to 1206 | 418 to 14 | | | Submitted on the opposite strand | 405/421 (96 %) | 7 diff (98.4 %id) |
BF821346 | kidney_tumor | .g | 806 to 1213 | 418 to 13 | | | Submitted on the opposite strand | 406/419 (96 %) | 5 diff (98.9 %id) |
BF897211 | marrow | .g | 807 to 1194 | 21 to 409 | | | | 389/409 (95 %) | 12 diff (97.1 %id) |
BF927677 | nervous_tumor | .g | 807 to 1194 | 388 to 1 | | | Submitted on the opposite strand | 388/417 (93 %) | 4 diff (99.1 %id) |
BI868296 | adenocarcinoma, cell line, Liver | .g | 938 to 1792 | 1 to 846 | | | | 846/859 (98 %) | 24 diff (97.3 %id) |
TI_57227951 | | .g | 938 to 1792 | 54 to 899 | | | | 846/859 (98 %) | 24 diff (97.3 %id) |
BQ292390 | amnion_normal | .g | 987 to 1246 | 10 to 266 | | | | 257/278 (92 %) | 6 diff (97.9 %id) |
DA715821 | | .g | 987 to 1523 | 2 to 538 | | capped | | 537/537 (100 %) | 0 diff (100 %id) |
BG386716 | adenocarcinoma cell line, colon | .g | 1036 to 1762 | 1 to 724 | | | | 724/724 (100 %) | 5 diff (99.4 %id) |
AW372136 | breast | .g | 1073 to 1284 | 211 to 1 | | | | 211/211 (100 %) | 3 diff (98.6 %id) |
AW372165 | breast | .g | 1073 to 1282 | 211 to 2 | | | | 210/211 (99 %) | 1 diff (99.6 %id) |
BU170878 | eye, retinoblastoma | .g | 1087 to 1884 | 47 to 850 | | | | 804/911 (88 %) | 16 diff (98.3 %id) |
BQ673244 | epidermoid carcinoma, cell line, salivary gland | .g | 1108 to 1862 | 1 to 762 | | | | 762/947 (80 %) | 18 diff (98.1 %id) |
DA816869 | | .g | 1115 to 1620 | 2 to 507 | | capped | | 506/506 (100 %) | 1 diff (99.9 %id) |
DA849986 | placenta | .g | 1164 to 1698 | 2 to 536 | | capped | | 535/535 (100 %) | 0 diff (100 %id) |
BG992004 | head_neck | .g | 1188 to 1531 | 387 to 37 | | | | 351/387 (90 %) | 0 diff (100 %id) |
DB129487 | thymus | .g | 1189 to 1727 | 2 to 540 | | capped | | 539/539 (100 %) | 1 diff (99.9 %id) |
BI023532 | marrow | .g | 1191 to 1334 | 1 to 144 | | | | 144/144 (100 %) | 6 diff (95.9 %id) |
BI223159 | cervical carcinoma cell line, cervix | .g | 1424 to 2169 | 1 to 745 | | | | 745/763 (97 %) | 6 diff (99.3 %id) |
BG686233 | B-cells, primary B-cells from tonsils (cell line) | .g | 1429 to 2172 | 1 to 746 | | | | 746/747 (99 %) | 8 diff (99.0 %id) |
BF035049 | adenocarcinoma, ovary | .g | 1626 to 2324 | 1 to 695 | | | | 695/695 (100 %) | 6 diff (99.2 %id) |
CO245356 | Chondrosarcoma Lung Metastasis cell lines, lung | .g | 1647 to 2336 | 1 to 685 | | | | 685/808 (84 %) | 14 diff (98.3 %id) |
BF095229 | uterus_tumor | .g | 1803 to 2188 | 386 to 1 | | | | 386/386 (100 %) | 1 diff (99.8 %id) |
CB270799 | adipose | .g | 1896 to 2331 | 1 to 436 | | | | 436/436 (100 %) | 1 diff (99.8 %id) |
AA456516 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .g | 1913 to 2262 | 1 to 350 | | | | 350/350 (100 %) | 1 diff (99.8 %id) |
DA672828 | | .g | 2127 to 2723 | 2 to 598 | | capped | | 597/597 (100 %) | 5 diff (99.2 %id) |
TI_151798396 | | .g | 2151 to 2782 | 107 to 734 | | | | 628/628 (100 %) | 19 diff (97.0 %id) |
BG113850 | Bone, osteosarcoma, cell line | .g | 2170 to 2773 | 1 to 615 | | | | 615/905 (67 %) | 43 diff (95.3 %id) |
BQ961914 | epithelioid carcinoma cell line, Pancreas | .g | 2171 to 2615 | 16 to 460 | | | | 445/464 (95 %) | 6 diff (98.8 %id) |
AW371248 | breast | .g | 2183 to 2323 | 27 to 165 | | | | 139/165 (84 %) | 6 diff (96.4 %id) |
CN278498 | embryonic stem cells, DMSO-treated H9 cellline | .g | 2299 to 2562 | 1 to 264 | | | | 264/264 (100 %) | 6 diff (97.8 %id) |
BM790953 | stomach | .g | 2305 to 2594 | 1 to 290 | | | | 290/290 (100 %) | 0 diff (100 %id) |
R01377 | liver and spleen | .g | 2328 to 2586 | 1 to 262 | | | | 262/266 (98 %) | 7 diff (97.4 %id) |
R01044 | liver and spleen | .g | 2328 to 2654 | 1 to 333 | | | | 333/334 (99 %) | 17 diff (95.0 %id) |
DB366236 | | .g | 2570 to 3159 | 592 to 1 | | | | 592/598 (98 %) | 30 diff (95.0 %id) |
DB366080 | | .g | 2603 to 3156 | 553 to 1 | | | | 553/565 (97 %) | 9 diff (98.5 %id) |
DB368175 | | .g | 2620 to 3159 | 539 to 1 | | | | 539/548 (98 %) | 14 diff (97.5 %id) |
DB364766 | | .g | 2629 to 3159 | 527 to 1 | | | | 527/551 (95 %) | 15 diff (97.3 %id) |
DB324639 | | .g | 2641 to 3159 | 519 to 1 | | | | 519/519 (100 %) | 1 diff (99.9 %id) |
R01263 | liver and spleen | .g | 2747 to 3152 | 409 to 1 | | | | 409/409 (100 %) | 10 diff (97.6 %id) |
R01045 | liver and spleen | .g | 2764 to 3157 | 408 to 9 | | | | 400/461 (86 %) | 0 diff (100 %id) |
DB328708 | placenta | .g | 2767 to 3159 | 395 to 1 | | | | 395/395 (100 %) | 3 diff (99.3 %id) |
ES308477 | beard hair, skin | .h | 1 to 190 | 1 to 188 | | tiling clone, | | 188/188 (100 %) | 5 diff (97.4 %id) |
CR991057 | T-Lymphocytes | .h | 57 to 646 | 1 to 591 | | tiling clone, | | 591/591 (100 %) | 2 diff (99.7 %id) |
DB466219 | hippocampus | .h | 259 to 685 | 1 to 427 | | | | 427/427 (100 %) | 11 diff (97.5 %id) |
BG771798 | testis | .h | 265 to 1082 | 1 to 829 | | tiling clone, | | 829/935 (88 %) | 23 diff (97.6 %id) |
BP352122 | | .h | 266 to 845 | 1 to 581 | | tiling clone, | | 581/581 (100 %) | 1 diff (99.9 %id) |
BI765617 | pooled colon, kidney, stomach | .h | 269 to 1075 | 26 to 830 | | tiling clone, | | 805/832 (96 %) | 12 diff (98.6 %id) |
TI_57147060 | | .h | 269 to 1075 | 26 to 830 | | | | 805/832 (96 %) | 12 diff (98.6 %id) |
BU158406 | large cell carcinoma, lung | .h | 272 to 1067 | 1 to 800 | | | | 800/813 (98 %) | 6 diff (99.3 %id) |
DA926132 | small intestine | .h | 274 to 843 | 2 to 571 | | capped | | 570/570 (100 %) | 0 diff (100 %id) |
DB450757 | testis | .h | 279 to 771 | 1 to 494 | | | | 494/494 (100 %) | 3 diff (99.4 %id) |
DB472117 | hippocampus | .h | 279 to 777 | 1 to 498 | | | | 498/498 (100 %) | 2 diff (99.6 %id) |
DB478067 | hippocampus | .h | 279 to 779 | 1 to 500 | | | | 500/500 (100 %) | 2 diff (99.6 %id) |
CD557968 | testis | .h | 279 to 1123 | 27 to 878 | | tiling clone, | | 852/878 (97 %) | 17 diff (98.1 %id) |
BP381930 | adipose tissue | .h | 281 to 895 | 1 to 615 | | | | 615/615 (100 %) | 0 diff (100 %id) |
DB496267 | hypothalamus | .h | 281 to 750 | 1 to 470 | | | | 470/470 (100 %) | 1 diff (99.8 %id) |
BG831593 | epithelioid carcinoma cell line, Pancreas | .h | 290 to 438 | 1 to 149 | G201W V202G R203T S204L N205Q ... | | | 920/920 (100 %) | 15 diff (98.4 %id) |
BG831582 | epithelioid carcinoma cell line, Pancreas | .h | 290 to 438 | 1 to 149 | S240L L241C F242S L243V S244G ... | | | 912/913 (99 %) | 16 diff (98.3 %id) |
BG332007 | large cell carcinoma, lung | .h | 292 to 996 | 1 to 705 | | | | 705/705 (100 %) | 0 diff (100 %id) |
CR599392 | Placenta Cot 25-normalized | .i | 1 to 1410 | 1 to 1410 | exact | tiling clone, | | 1410/1410 (100 %) | 0 diff (100 %id) |
BX335760 | Placenta Cot 25-normalized | .i | 1 to 806 | 1 to 803 | | fully sequenced, | | 803/803 (100 %) | 14 diff (98.3 %id) |
BX392535 | Placenta Cot 25-normalized | .i | 776 to 1409 | 635 to 1 | | fully sequenced, | | 635/635 (100 %) | 11 diff (98.3 %id) |
AK301626 | colon, tumor tissue | .j | 1 to 1464 | 1 to 1464 | exact | tiling clone, | | 1464/1464 (100 %) | 0 diff (100 %id) |
DC393683 | colon, tumor tissue | .j | 1 to 563 | 1 to 563 | | | | 563/563 (100 %) | 0 diff (100 %id) |
DA672272 | | .k | 1 to 583 | 2 to 584 | | capped | | 583/583 (100 %) | 0 diff (100 %id) |
DA675243 | | .k | 1 to 601 | 2 to 602 | | tiling clone, capped | | 601/601 (100 %) | 0 diff (100 %id) |
DA672617 | | .k | 4 to 596 | 2 to 594 | | capped | | 593/593 (100 %) | 0 diff (100 %id) |
BM765382 | Ascites, stomach | .k | 425 to 1012 | 1 to 588 | | | | 588/588 (100 %) | 4 diff (99.4 %id) |
BM771108 | Ascites, stomach | .k | 425 to 997 | 1 to 573 | | | | 573/573 (100 %) | 1 diff (99.9 %id) |
BM770617 | Ascites, stomach | .k | 425 to 1004 | 1 to 580 | | tiling clone, | | 580/580 (100 %) | 0 diff (100 %id) |
R21083 | whole brain | .k | 605 to 1019 | 1 to 425 | | | | 425/435 (97 %) | 20 diff (95.5 %id) |
R35607 | whole brain | .k | 605 to 906 | 1 to 303 | | | | 303/306 (99 %) | 3 diff (99.1 %id) |
H12163 | whole brain | .k | 605 to 975 | 1 to 378 | | | | 378/385 (98 %) | 10 diff (97.5 %id) |
BF789890 | muscle (skeletal) | .k | 650 to 1090 | 1 to 447 | | | | 447/967 (46 %) | 13 diff (98.7 %id) |
BM929476 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .k | 947 to 1490 | 1 to 544 | | tiling clone, | | 544/544 (100 %) | 0 diff (100 %id) |
CR745440 | | .k | 1082 to 1697 | 632 to 15 | | AAA | Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) | 618/620 (99 %) | 3 diff (99.6 %id) |
BM719656 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .k | 1194 to 1699 | 1 to 506 | | AAA | Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) | 506/506 (100 %) | 1 diff (99.9 %id) |
DB568342 | hypothalamus | .k | 1237 to 1695 | 1 to 458 | | | Submitted on the opposite strand | 458/460 (99 %) | 4 diff (99.2 %id) |
BX091208 | whole brain | .k | 1260 to 1697 | 452 to 15 | | AAA | Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) | 438/441 (99 %) | 2 diff (99.6 %id) |
AW165966 | brain, medulloblastoma | .k | 1295 to 1701 | 409 to 2 | | tiling clone, | | 408/409 (99 %) | 0 diff (100 %id) |
H11642 | whole brain | .k | 1324 to 1679 | 358 to 1 | | | | 358/360 (99 %) | 5 diff (98.7 %id) |
R46259 | whole brain | .k | 1337 to 1693 | 382 to 15 | | | | 368/384 (95 %) | 0 diff (100 %id) |
AW290935 | | .k | 1429 to 1700 | 290 to 18 | | AAA | Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) | 273/276 (98 %) | 4 diff (98.6 %id) |
AW474030 | lymph node, lymphoma, follicular mixed small and largecell | .k | 1462 to 1698 | 238 to 3 | | | | 236/238 (99 %) | 0 diff (100 %id) |
AI198914 | | .k | 1470 to 1701 | 233 to 3 | | | | 231/233 (99 %) | 0 diff (100 %id) |
DA676934 | | .l | 1 to 562 | 2 to 563 | | tiling clone, capped | | 562/562 (100 %) | 0 diff (100 %id) |
BJ993380 | hepatoblastoma | .l | 3 to 533 | 1 to 531 | | | | 531/531 (100 %) | 0 diff (100 %id) |
AK298683 | | .l | 13 to 1001 | 1 to 989 | exact | tiling clone, | | 989/989 (100 %) | 1 diff (99.9 %id) |
DA672996 | | .l | 14 to 610 | 2 to 598 | | capped | | 597/597 (100 %) | 0 diff (100 %id) |
DA676633 | | .l | 17 to 593 | 2 to 578 | | capped | | 577/577 (100 %) | 0 diff (100 %id) |
CR614359 | Neuroblastoma Cot 10-normalized | .l | 962 to 2716 | 1 to 1755 | | tiling clone, | | 1755/1755 (100 %) | 0 diff (100 %id) |
AL521319 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .l | 962 to 1833 | 1 to 872 | | fully sequenced, | | 872/872 (100 %) | 3 diff (99.7 %id) |
CR600621 | T cells (Jurkat cell line) Cot10-normalized | .l | 1319 to 2694 | 1 to 1376 | | | | 1376/1376 (100 %) | 0 diff (100 %id) |
AL559596 | T cells from T cell leukemia | .l | 1319 to 2325 | 1 to 990 | | | | 990/1026 (96 %) | 32 diff (96.9 %id) |
Z45373 | brain, total brain | .l | 1505 to 1814 | 1 to 310 | | | | 310/310 (100 %) | 0 diff (100 %id) |
BM723804 | eye, fetal eye | .l | 1507 to 2121 | 1 to 614 | | | | 614/614 (100 %) | 3 diff (99.6 %id) |
BQ711765 | Spleen | .l | 1525 to 2205 | 18 to 701 | | | | 684/983 (69 %) | 7 diff (99.3 %id) |
BE779574 | eye, retinoblastoma | .l | 1529 to 2187 | 1 to 650 | | | | 650/656 (99 %) | 22 diff (96.7 %id) |
BU838622 | epidermoid carcinoma, cell line, salivary gland | .l | 1561 to 2190 | 1 to 634 | | | | 634/934 (67 %) | 23 diff (97.6 %id) |
H17390 | whole brain | .l | 1583 to 2078 | 1 to 492 | | | | 492/556 (88 %) | 13 diff (97.7 %id) |
BQ051394 | large cell carcinoma, lung | .l | 1620 to 2203 | 1 to 585 | | | | 585/589 (99 %) | 4 diff (99.4 %id) |
BG773853 | choriocarcinoma, placenta | .l | 1658 to 2202 | 1 to 545 | | | | 545/545 (100 %) | 0 diff (100 %id) |
CD671312 | eye, Iris | .l | 1679 to 2274 | 1 to 596 | | | | 596/596 (100 %) | 0 diff (100 %id) |
AL561980 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .l | 1803 to 2716 | 913 to 1 | | fully sequenced, | | 913/913 (100 %) | 5 diff (99.5 %id) |
TI_227714009 | | .l | 1923 to 2754 | 905 to 91 | | AAA | | 815/974 (83 %) | 24 diff (97.6 %id) |
DB272117 | uterus | .l | 1964 to 2401 | 2 to 439 | | capped | | 438/438 (100 %) | 2 diff (99.6 %id) |
BI093184 | cervix | .l | 1979 to 2753 | 1 to 772 | | | | 772/793 (97 %) | 10 diff (98.8 %id) |
TI_159718718 | | .l | 1991 to 2754 | 854 to 97 | | AAA | | 758/956 (79 %) | 22 diff (97.7 %id) |
BG168720 | hypernephroma, cell line, Kidney | .l | 2007 to 2730 | 1 to 722 | | | | 722/914 (78 %) | 25 diff (97.3 %id) |
BQ181772 | Knee, Osteoarthritic Cartilage | .l | 2007 to 2754 | 762 to 16 | | AAA | | 747/747 (100 %) | 4 diff (99.5 %id) |
BX279749 | cervix | .l | 2026 to 2480 | 1 to 455 | | | | 455/455 (100 %) | 0 diff (100 %id) |
CR985977 | T-Lymphocytes | .l | 2026 to 2642 | 1 to 617 | | | | 617/619 (99 %) | 1 diff (99.9 %id) |
CR989327 | T-Lymphocytes | .l | 2026 to 2545 | 1 to 520 | | | | 520/520 (100 %) | 0 diff (100 %id) |
TI_159718694 | | .l | 2027 to 2754 | 808 to 85 | | AAA | | 724/988 (73 %) | 27 diff (97.3 %id) |
AA343284 | Spleen | .l | 2044 to 2367 | 1 to 326 | | | | 326/326 (100 %) | 3 diff (99.1 %id) |
TI_149285831 | | .l | 2048 to 2754 | 786 to 86 | | AAA | | 701/706 (99 %) | 8 diff (98.9 %id) |
BU617760 | Bone, Subchondral Bone | .l | 2058 to 2754 | 715 to 19 | | AAA | | 697/697 (100 %) | 0 diff (100 %id) |
CB147711 | Liver | .l | 2068 to 2220 | 1 to 153 | | | | 153/153 (100 %) | 0 diff (100 %id) |
R28531 | placenta | .l | 2082 to 2387 | 1 to 312 | | | | 312/314 (99 %) | 12 diff (96.2 %id) |
W29089 | eye, retina | .l | 2082 to 2698 | 657 to 38 | | | | 620/864 (71 %) | 0 diff (100 %id) |
AA987477 | carcinoid, lung | .l | 2106 to 2470 | 1 to 364 | | | Submitted on the opposite strand | 364/364 (100 %) | 8 diff (97.9 %id) |
CB529912 | Aveolar Macrophage, lung | .l | 2122 to 2754 | 648 to 16 | | AAA | | 633/633 (100 %) | 0 diff (100 %id) |
CN425771 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .l | 2131 to 2282 | 1 to 152 | | | | 152/152 (100 %) | 0 diff (100 %id) |
BQ015042 | Chondrosarcoma, Left Pubic Bone | .l | 2132 to 2754 | 639 to 19 | | AAA | | 621/632 (98 %) | 3 diff (99.6 %id) |
BM679985 | eye, fetal eye | .l | 2132 to 2754 | 638 to 16 | | AAA | | 623/634 (98 %) | 0 diff (100 %id) |
CD364741 | Alveolar Macrophage, lung | .l | 2132 to 2754 | 641 to 19 | | AAA | | 623/634 (98 %) | 1 diff (99.9 %id) |
BM971697 | lung | .l | 2133 to 2754 | 636 to 16 | | AAA | | 621/621 (100 %) | 2 diff (99.7 %id) |
BU609199 | Human Lung Epithelial cells, lung | .l | 2133 to 2754 | 637 to 16 | | AAA | | 622/622 (100 %) | 1 diff (99.9 %id) |
CB241473 | Human Lung Epithelial cells, lung | .l | 2135 to 2754 | 636 to 16 | | AAA | | 621/621 (100 %) | 1 diff (99.9 %id) |
CB852692 | Human Lung Epithelial cells, lung | .l | 2147 to 2754 | 623 to 16 | | AAA | | 608/608 (100 %) | 0 diff (100 %id) |
BQ015784 | lung, Metastatic Chondrosarcoma | .l | 2170 to 2754 | 600 to 16 | | AAA | | 585/585 (100 %) | 3 diff (99.5 %id) |
BM665911 | eye, fetal eyes | .l | 2173 to 2754 | 597 to 16 | | AAA | | 582/582 (100 %) | 1 diff (99.9 %id) |
AI262246 | Kidney | .l | 2183 to 2755 | 567 to 1 | | | | 567/567 (100 %) | 22 diff (96.2 %id) |
H18080 | whole brain | .l | 2187 to 2755 | 568 to 8 | | | | 561/586 (95 %) | 0 diff (100 %id) |
TI_157611536 | | .l | 2197 to 2754 | 651 to 94 | | AAA | | 558/573 (97 %) | 59 diff (89.8 %id) |
CO397144 | Chondrosarcoma Lung Metastasis cell lines, lung | .l | 2198 to 2751 | 1 to 549 | | AAA | | 549/549 (100 %) | 12 diff (97.9 %id) |
BM664541 | eye, human retina | .l | 2201 to 2754 | 567 to 16 | | AAA | | 552/552 (100 %) | 5 diff (99.1 %id) |
AA829631 | germinal center B cell | .l | 2206 to 2754 | 559 to 11 | | AAA | | 549/549 (100 %) | 2 diff (99.7 %id) |
BY798518 | eye | .l | 2212 to 2755 | 1 to 543 | | | | 543/543 (100 %) | 1 diff (99.9 %id) |
BP429657 | | .l | 2213 to 2613 | 1 to 401 | | | | 401/401 (100 %) | 4 diff (99.1 %id) |
BU594660 | mixed (pool of 40 RNAs) | .l | 2215 to 2755 | 1 to 541 | | | | 541/873 (61 %) | 7 diff (99.2 %id) |
BM803945 | duodenal adenocarcinoma, cell line, small intestine | .l | 2217 to 2758 | 560 to 17 | | AAA | Submitted on the opposite strand | 544/1073 (50 %) | 4 diff (99.7 %id) |
BF984318 | duodenal adenocarcinoma, cell line, small intestine | .l | 2220 to 2754 | 17 to 551 | | AAA | | 535/551 (97 %) | 6 diff (99.0 %id) |
EL951513 | eyeball | .l | 2231 to 2738 | 46 to 552 | | | | 507/552 (91 %) | 6 diff (99.0 %id) |
BF325674 | amnion_normal | .l | 2253 to 2545 | 288 to 1 | | | | 288/290 (99 %) | 8 diff (97.3 %id) |
AI401629 | brain, glioblastoma (pooled) | .l | 2256 to 2751 | 495 to 1 | | | | 495/495 (100 %) | 3 diff (99.4 %id) |
AW269392 | pooled | .l | 2256 to 2754 | 499 to 1 | | | | 499/499 (100 %) | 3 diff (99.4 %id) |
BE855629 | brain, glioblastoma (pooled) | .l | 2256 to 2751 | 495 to 1 | | | | 495/495 (100 %) | 3 diff (99.4 %id) |
AI023778 | liver and spleen | .l | 2257 to 2758 | 503 to 2 | | | | 502/503 (99 %) | 0 diff (100 %id) |
AA854845 | parathyroid gland, parathyroid tumor | .l | 2261 to 2755 | 498 to 6 | | | | 493/498 (98 %) | 0 diff (100 %id) |
CA431020 | cell lines, Chondrosarcoma | .l | 2264 to 2759 | 514 to 19 | | tiling clone, AAA | | 496/496 (100 %) | 0 diff (100 %id) |
AI246715 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .l | 2278 to 2755 | 482 to 5 | | | | 478/482 (99 %) | 0 diff (100 %id) |
BU566176 | mixed (pool of 40 RNAs) | .l | 2278 to 2756 | 1 to 479 | | | | 479/485 (98 %) | 2 diff (99.6 %id) |
AW303449 | pooled | .l | 2291 to 2755 | 469 to 5 | | | | 465/469 (99 %) | 0 diff (100 %id) |
BF591484 | brain, glioblastoma (pooled) | .l | 2291 to 2751 | 463 to 1 | | | | 463/463 (100 %) | 3 diff (99.4 %id) |
AI092632 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .l | 2296 to 2758 | 463 to 1 | | | | 463/463 (100 %) | 0 diff (100 %id) |
AA047777 | heart | .l | 2299 to 2752 | 1 to 456 | | fully sequenced, | | 456/456 (100 %) | 9 diff (98.1 %id) |
AA215551 | germinal center B cell | .l | 2303 to 2750 | 455 to 1 | | | Submitted on the opposite strand | 455/456 (99 %) | 12 diff (97.4 %id) |
AA807067 | germinal center B cell | .l | 2304 to 2754 | 466 to 11 | | AAA | | 456/456 (100 %) | 30 diff (93.5 %id) |
BJ993381 | hepatoblastoma | .l | 2307 to 2722 | 416 to 1 | | | | 416/416 (100 %) | 0 diff (100 %id) |
AW130314 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .l | 2307 to 2754 | 448 to 1 | | | | 448/448 (100 %) | 0 diff (100 %id) |
AW340516 | pooled | .l | 2307 to 2753 | 452 to 6 | | | | 447/452 (98 %) | 0 diff (100 %id) |
AI367155 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .l | 2311 to 2754 | 444 to 1 | | | | 444/444 (100 %) | 1 diff (99.8 %id) |
BF032840 | adenocarcinoma, ovary | .l | 2319 to 2754 | 1 to 436 | | AAA | | 436/436 (100 %) | 0 diff (100 %id) |
AI369370 | anaplastic oligodendroglioma, brain | .l | 2320 to 2754 | 435 to 1 | | | | 435/435 (100 %) | 0 diff (100 %id) |
AI023788 | liver and spleen | .l | 2321 to 2758 | 439 to 2 | | | | 438/439 (99 %) | 0 diff (100 %id) |
AW029360 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .l | 2323 to 2754 | 470 to 38 | | AAA | | 433/433 (100 %) | 18 diff (95.9 %id) |
AA954407 | pooled | .l | 2328 to 2758 | 424 to 1 | | | | 424/424 (100 %) | 8 diff (98.2 %id) |
AI151381 | placenta | .l | 2329 to 2755 | 427 to 1 | | | | 427/427 (100 %) | 0 diff (100 %id) |
AI248659 | liver and spleen | .l | 2329 to 2758 | 429 to 1 | | | | 429/429 (100 %) | 1 diff (99.8 %id) |
AI633595 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .l | 2332 to 2754 | 434 to 12 | | AAA | | 423/423 (100 %) | 1 diff (99.8 %id) |
AW439584 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .l | 2335 to 2758 | 425 to 1 | | | | 425/425 (100 %) | 3 diff (99.3 %id) |
AA961013 | carcinoid, lung | .l | 2344 to 2755 | 413 to 3 | | | | 411/414 (99 %) | 0 diff (100 %id) |
AW183522 | pooled | .l | 2344 to 2755 | 415 to 3 | | | | 413/415 (99 %) | 0 diff (100 %id) |
AA960799 | pooled | .l | 2358 to 2754 | 397 to 1 | | | | 397/397 (100 %) | 2 diff (99.5 %id) |
BG163744 | hypernephroma, cell line, Kidney | .l | 2358 to 2754 | 1 to 396 | | AAA | | 396/396 (100 %) | 1 diff (99.8 %id) |
AI401027 | B-cell, chronic lymphotic leukemia | .l | 2359 to 2755 | 397 to 1 | | | | 397/397 (100 %) | 0 diff (100 %id) |
AI684684 | pooled | .l | 2359 to 2754 | 396 to 1 | | | | 396/396 (100 %) | 0 diff (100 %id) |
AI332436 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .l | 2360 to 2751 | 392 to 1 | | | | 392/392 (100 %) | 0 diff (100 %id) |
T35017 | placenta | .l | 2371 to 2751 | 380 to 1 | | | | 380/380 (100 %) | 1 diff (99.8 %id) |
AW193632 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .l | 2393 to 2755 | 369 to 7 | | | | 363/399 (90 %) | 0 diff (100 %id) |
AA844130 | parathyroid gland, parathyroid tumor | .l | 2403 to 2755 | 356 to 6 | | | | 351/356 (98 %) | 0 diff (100 %id) |
AI784083 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .l | 2405 to 2751 | 349 to 1 | | | | 349/349 (100 %) | 2 diff (99.5 %id) |
AI863839 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .l | 2447 to 2754 | 309 to 1 | | | | 309/309 (100 %) | 1 diff (99.7 %id) |
BU676699 | lung, Primary Lung Epithelial Cells | .l | 2453 to 2754 | 317 to 16 | | AAA | | 302/676 (44 %) | 1 diff (99.9 %id) |
AI745525 | Prostate | .l | 2456 to 2754 | 313 to 15 | | AAA | | 299/299 (100 %) | 0 diff (100 %id) |
AA812551 | | .l | 2488 to 2755 | 270 to 3 | | | | 268/270 (99 %) | 0 diff (100 %id) |
AA926756 | pooled | .l | 2489 to 2755 | 267 to 1 | | | | 267/267 (100 %) | 0 diff (100 %id) |
Z41087 | brain, total brain | .l | 2492 to 2754 | 263 to 1 | | | | 263/263 (100 %) | 0 diff (100 %id) |
AA057780 | heart | .l | 2500 to 2754 | 264 to 1 | | fully sequenced, | | 264/264 (100 %) | 3 diff (98.9 %id) |
AA906623 | carcinoid, lung | .l | 2501 to 2755 | 257 to 3 | | | | 255/257 (99 %) | 0 diff (100 %id) |
C00471 | | .l | 2524 to 2758 | 1 to 235 | | | | 235/235 (100 %) | 0 diff (100 %id) |
BF057468 | fibrotheoma, ovary | .l | 2543 to 2755 | 213 to 1 | | | | 213/213 (100 %) | 2 diff (99.1 %id) |
AI342140 | uterus | .l | 2546 to 2754 | 228 to 20 | | AAA | | 209/209 (100 %) | 7 diff (96.7 %id) |
AI000681 | breast | .l | 2625 to 2754 | 130 to 1 | | | | 130/130 (100 %) | 0 diff (100 %id) |
AA515557 | lung, lung tumor | .l | 2683 to 2755 | 77 to 5 | | | | 73/77 (94 %) | 0 diff (100 %id) |
CN425770 | embryonic stem cells, cell lines H1, H7, andH9 | .m-u | 1 to 494 | 1 to 495 | | tiling clone, | | 495/495 (100 %) | 5 diff (99.0 %id) |
AK091260 | tongue, tumor tissue | .m-u | 171 to 2872 | 1 to 2702 | exact | tiling clone, available from FLJ, | | 2702/2702 (100 %) | 3 diff (99.9 %id) |
AX746882 | | .m-u | 171 to 2872 | 1 to 2702 | exact | | | 2702/2702 (100 %) | 3 diff (99.9 %id) |
DA446936 | tongue, tumor tissue | .m-u | 172 to 738 | 2 to 568 | | capped | | 567/567 (100 %) | 1 diff (99.9 %id) |
DB314022 | tongue, tumor tissue | .m-u | 2340 to 2872 | 533 to 1 | | | | 533/533 (100 %) | 1 diff (99.9 %id) |
DW441410 | Liver | .m-u | 2455 to 2676 | 17 to 238 | | | | 222/238 (93 %) | 9 diff (96.3 %id) |
AI681283 | carcinoid, lung | .m-u | 2576 to 2871 | 296 to 1 | | | | 296/320 (92 %) | 1 diff (99.7 %id) |
N36540 | melanocyte | .m-u | 2668 to 2855 | 187 to 1 | | | Submitted on the opposite strand | 187/187 (100 %) | 2 diff (99.0 %id) |
AA372014 | parathyroid gland | .m-u | 2726 to 2872 | 147 to 1 | | | | 147/147 (100 %) | 0 diff (100 %id) |
AI632590 | pooled germ cell tumors | .n | 1 to 341 | 1 to 341 | | tiling clone, | Submitted on the opposite strand | 341/341 (100 %) | 3 diff (99.2 %id) |
BX103927 | | .n | 8 to 450 | 443 to 1 | | | Submitted on the opposite strand | 443/455 (97 %) | 0 diff (100 %id) |
AI016089 | | .n | 8 to 399 | 7 to 398 | | | Submitted on the opposite strand | 392/398 (98 %) | 6 diff (98.5 %id) |
AI025535 | | .n | 8 to 259 | 1 to 252 | | | Submitted on the opposite strand | 252/252 (100 %) | 3 diff (98.9 %id) |
AI798773 | pooled | .n | 8 to 573 | 1 to 566 | | | Submitted on the opposite strand | 566/566 (100 %) | 1 diff (99.9 %id) |
DA856518 | placenta | .n | 127 to 658 | 2 to 533 | | capped | | 532/570 (93 %) | 4 diff (99.3 %id) |
BM918739 | pooled pancreas and spleen | .n | 157 to 668 | 70 to 582 | | | | 513/1370 (37 %) | 21 diff (98.5 %id) |
CD692394 | normal nasopharynx | .n | 321 to 928 | 22 to 629 | | tiling clone, | | 608/629 (96 %) | 7 diff (98.9 %id) |
DA709029 | | .n | 388 to 938 | 2 to 552 | | capped | | 551/551 (100 %) | 0 diff (100 %id) |
DA177069 | amygdala | .n | 399 to 939 | 2 to 542 | | capped | | 541/541 (100 %) | 0 diff (100 %id) |
BP382023 | adipose tissue | .n | 415 to 1030 | 1 to 616 | | | | 616/616 (100 %) | 0 diff (100 %id) |
DA176996 | amygdala | .n | 523 to 1040 | 2 to 520 | | tiling clone, capped | | 519/519 (100 %) | 2 diff (99.7 %id) |
DB210285 | trachea | .n | 524 to 1106 | 2 to 588 | L105F R106T L108V L109T S110E ... | tiling clone, capped | | 587/587 (100 %) | 4 diff (99.4 %id) |
DB251665 | uterus | .n | 524 to 1069 | 2 to 547 | | tiling clone, capped | | 546/546 (100 %) | 2 diff (99.7 %id) |
BE906872 | epithelioid carcinoma, Pancreas | .o-u | 1 to 693 | 1 to 687 | P114L P115H P116L A117L | tiling clone, | | 687/757 (90 %) | 14 diff (98.2 %id) |
DA259672 | caudate nucleus | .p-u | 1 to 499 | 2 to 500 | | tiling clone, capped | | 499/499 (100 %) | 1 diff (99.8 %id) |
H11936 | whole brain | .p-u | 4 to 396 | 1 to 395 | | | | 395/411 (96 %) | 7 diff (98.3 %id) |
AK097053 | small intestine | .p-u | 227 to 1946 | 1 to 1720 | exact | tiling clone, available from FLJ, | | 1720/1720 (100 %) | 2 diff (99.9 %id) |
DA928632 | small intestine | .p-u | 228 to 781 | 2 to 555 | | capped | | 554/554 (100 %) | 2 diff (99.7 %id) |
BX508720 | | .p-u | 291 to 891 | 1 to 601 | | | | 601/601 (100 %) | 3 diff (99.6 %id) |
R55111 | whole brain | .p-u | 414 to 472 | 425 to 486 | | | | 468/497 (94 %) | 19 diff (96.2 %id) |
AA262855 | germinal center B cell | .p-u | 700 to 1116 | 1 to 417 | | | | 417/417 (100 %) | 0 diff (100 %id) |
CK004873 | brain/CNS, Human Brain - Frontal Cortex | .p-u | 752 to 1273 | 1 to 519 | | | | 519/565 (91 %) | 16 diff (97.2 %id) |
BF531024 | anaplastic oligodendroglioma with 1p/19qloss, brain | .p-u | 1121 to 1904 | 1 to 784 | L46C Y47I H48T W49G T51P ... | | | 784/914 (85 %) | 28 diff (97.0 %id) |
DB332223 | small intestine | .p-u | 1403 to 1946 | 544 to 1 | | | | 544/544 (100 %) | 0 diff (100 %id) |
H11937 | whole brain | .p-u | 1526 to 1951 | 463 to 30 | | tiling clone, AAA | | 434/436 (99 %) | 14 diff (96.8 %id) |
AW408061 | lymph | .q | 1 to 495 | 1 to 495 | L2E | tiling clone, | | 495/495 (100 %) | 4 diff (99.2 %id) |
TI_154147388 | | .q | 7 to 865 | 78 to 933 | | tiling clone, | | 856/856 (100 %) | 58 diff (93.3 %id) |
AI298425 | carcinoid, lung | .q | 14 to 332 | 319 to 1 | | | | 319/319 (100 %) | 1 diff (99.7 %id) |
AI703083 | carcinoid, lung | .q | 14 to 332 | 319 to 1 | | | | 319/319 (100 %) | 0 diff (100 %id) |
BE218594 | carcinoid, lung | .q | 14 to 332 | 319 to 1 | | | | 319/319 (100 %) | 0 diff (100 %id) |
BE550169 | carcinoid, lung | .q | 14 to 332 | 319 to 1 | | | | 319/319 (100 %) | 0 diff (100 %id) |
DA673959 | | .q | 696 to 1284 | 2 to 590 | | tiling clone, capped | | 589/589 (100 %) | 0 diff (100 %id) |
BG180578 | adenocarcinoma, cell line, Prostate | .q | 1003 to 1704 | 1 to 695 | | | | 695/905 (76 %) | 22 diff (97.6 %id) |
CD651897 | Embryonic Stem cells | .q | 1008 to 1774 | 53 to 811 | | tiling clone, | | 759/822 (92 %) | 19 diff (97.7 %id) |
AW867698 | stomach_normal | .q | 1128 to 1251 | 124 to 1 | | | | 124/138 (89 %) | 2 diff (98.6 %id) |
BM796778 | Ascites, stomach | .q | 1214 to 1691 | 1 to 478 | | | | 478/478 (100 %) | 3 diff (99.4 %id) |
BI116707 | lung, small cell carcinoma | .q | 1220 to 1791 | 1 to 570 | | | | 570/574 (99 %) | 17 diff (97.1 %id) |
BI870397 | adenocarcinoma, cell line, Liver | .q | 1230 to 1936 | 1 to 702 | | tiling clone, | | 702/702 (100 %) | 5 diff (99.3 %id) |
TI_57230873 | | .q | 1230 to 1936 | 46 to 747 | | | | 702/702 (100 %) | 5 diff (99.3 %id) |
BM836399 | myeloma | .q | 1305 to 1789 | 1 to 484 | | tiling clone, | | 484/484 (100 %) | 4 diff (99.2 %id) |
AA380755 | | .q | 1534 to 1811 | 1 to 281 | | | | 281/281 (100 %) | 3 diff (99.0 %id) |
DA384314 | thalamus | .r-u | 1 to 637 | 2 to 639 | D20G T21H A22G G23W L24A ... | tiling clone, capped | | 638/638 (100 %) | 1 diff (99.9 %id) |
AA054571 | uterus | .r-u | 617 to 906 | 1 to 289 | | tiling clone, | | 289/374 (77 %) | 4 diff (99.0 %id) |
BG772469 | testis | .s | 1 to 813 | 1 to 815 | exact | tiling clone, | | 815/815 (100 %) | 12 diff (98.6 %id) |
BP267114 | thyroid | .t | 1 to 582 | 1 to 581 | | tiling clone, | | 581/581 (100 %) | 2 diff (99.7 %id) |
BP266642 | thyroid | .t | 2 to 585 | 1 to 584 | exact | tiling clone, | | 584/584 (100 %) | 0 diff (100 %id) |
DB453193 | testis | .t | 24 to 521 | 1 to 497 | | | | 497/498 (99 %) | 3 diff (99.4 %id) |
DA478724 | | .u | 1 to 571 | 2 to 577 | exact | tiling clone, capped | | 576/576 (100 %) | 5 diff (99.2 %id) |
DB465413 | hippocampus | .u | 48 to 478 | 1 to 431 | | tiling clone, | | 431/431 (100 %) | 5 diff (98.9 %id) |
DA748632 | | .va-u | 1 to 564 | 2 to 565 | | tiling clone, capped | | 564/564 (100 %) | 0 diff (100 %id) |
DA676789 | | .vb-u | 1 to 563 | 2 to 564 | exact | tiling clone, capped | | 563/563 (100 %) | 1 diff (99.9 %id) |
DB458275 | testis | .vc | 1 to 465 | 1 to 465 | exact | tiling clone, | | 465/465 (100 %) | 2 diff (99.6 %id) |
DA151823 | amygdala | .vd | 1 to 450 | 9 to 459 | G14X E15G P16A R17P S19L ... | tiling clone, capped | | 458/458 (100 %) | 1 diff (99.8 %id) |
BI831404 | brain, medulla | .vd | 25 to 265 | 1 to 241 | | tiling clone, | | 241/241 (100 %) | 2 diff (99.2 %id) |
AA364127 | pineal body | Gene PIGVandZDHHC18, variant not shown | | | | | This clone was ignored | | |
AW955695 | | Gene PIGVandZDHHC18, variant not shown | | | | AAA | This clone was ignored | | |
CB155413 | brain | Gene PIGVandZDHHC18, variant not shown | | | | | This clone was ignored | | |
BP212950 | cerebrum | Gene PIGVandZDHHC18, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
AI279642 | lung | Gene PIGVandZDHHC18, variant not shown | | | | | Suspected internal deletion, suspected internal deletion, this clone was ignored | | |
AI911280 | pooled | Gene PIGVandZDHHC18, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
BU848794 | ovary, teratocarcinoma, cell line | Gene PIGVandZDHHC18, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
DR157388 | human embryonic stem cells differentiated toan early endodermal cell type | Gene PIGVandZDHHC18, variant not shown | | | | | Suspected internal deletion, suspected internal deletion, this clone was ignored | | |
BP310857 | brain | Gene PIGVandZDHHC18, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
DB057746 | testis | Gene PIGVandZDHHC18, variant not shown | | | | capped | This clone was ignored | | |
DB339033 | testis | Gene PIGVandZDHHC18, variant not shown | | | | | This clone was ignored | | |
DB209929 | trachea | Gene PIGVandZDHHC18, variant not shown | | | | capped | Suspected internal deletion, this clone was ignored | | |
? | Gene Summary |
Gene on genome |
mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o-u, .p-u, .q, .r-u, .s, .t, .u, .va-u, .vb-u, .vc, .vd |
Alternative mRNAs features, proteins, introns, exons, sequences |
Expression Tissue |
Function, regulation, related genes C |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !